• Shopping Cart
    There are no items in your cart

CLSI EP17 A2 : 2ED 2012

Current

Current

The latest, up-to-date edition.

EVALUATION OF DETECTION CAPABILITY FOR CLINICAL LABORATORY MEASUREMENT PROCEDURES

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

18-06-2012

€403.79
Excluding VAT

Abstract
Committee Membership
Foreword
1 Scope
2 Standard Precautions
3 Terminology
4 Background
5 Protocols for Evaluation of the Limit of Blank
  and Limit of Detection
6 Protocol for Evaluation of the Limit of Quantitation
7 Verification of Detection Capability Claims
8 Reporting Detection Capability
References
Appendix A - Worked Example: Evaluation of Limits
             of Blank and Detection by the Classical
             Approach
Appendix B - Worked Example: Evaluation of Limit
             of Detection by the Precision Profile Approach
Appendix C - Worked Example: Evaluation of Limit
             of Detection by the Probit Approach
Appendix D - Worked Examples: Evaluation of Limit
             of Quantitation
Appendix E - Worked Example: Verification of Limits
             of Blank and Detection Claims
Appendix F - Worked Example: Verification of Limit
             of Quantitation Claim
The Quality Management System Approach
Related CLSI Reference Materials

Gives guidance for evaluation and documentation of the detection capability of clinical laboratory measurement procedures (ie, limits of blank, detection, and quantitation), for verification of manufacturers' detection capability claims, and for the proper use and interpretation of different detection capability estimates.

DevelopmentNote
Supersedes CLSI EP17 A. (07/2012)
DocumentType
Miscellaneous Product
ISBN
1-56238-796-0
Pages
80
PublisherName
Clinical Laboratory Standards Institute
Status
Current
Supersedes

CLSI MM23 : 1ED 2015 MOLECULAR DIAGNOSTIC METHODS FOR SOLID TUMORS (NONHEMATOLOGICAL NEOPLASMS)
CLSI EP19 : 2ED 2015 A FRAMEWORK FOR USING CLSI DOCUMENTS TO EVALUATE CLINICAL LABORATORY MEASUREMENT PROCEDURES
CLSI MM7 A2 : 2ED 2013 FLUORESCENCE IN SITU HYBRIDIZATION METHODS FOR CLINICAL LABORATORIES
CLSI H48 : 2ED 2016 DETERMINATION OF COAGULATION FACTOR ACTIVITIES USING THE ONE-STAGE CLOTTING ASSAY
CLSI EP34:2018(R2023) Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking
CLSI C49:2018(R2023) Analysis of Body Fluids in Clinical Chemistry
CLSI NBS06 A : 1ED 2013 NEWBORN BLOOD SPOT SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY BY MEASUREMENT OF T-CELL RECEPTOR EXCISION CIRCLES
CLSI POCT17 : 1ED 2016 USE OF GLUCOSE METERS FOR CRITICALLY ILL PATIENTS
CLSI NBS07 : 1ED 2017 NEWBORN BLOOD SPOT SCREENING FOR POMPE DISEASE BY LYSOSOMAL ACID A-GLUCOSIDASE ACTIVITY ASSAYS
PD ISO/TS 17822-1:2014 <i>In</i> <i>vitro</i> diagnostic test systems. Qualitative nucleic acid-based <i>in</i> <i>vitro</i> examination procedures for detection and identification of microbial pathogens General requirements, terms and definitions
CLSI I/LA20 : 3ED 2016 ANALYTICAL PERFORMANCE CHARACTERISTICS, QUALITY ASSURANCE, AND CLINICAL UTILITY OF IMMUNOLOGICAL ASSAYS FOR HUMAN IMMUNOGLOBULIN E ANTIBODIES OF DEFINED ALLERGEN SPECIFICITIES
CLSI C57 : 1ED 2015 MASS SPECTROMETRY FOR ANDROGEN AND ESTROGEN MEASUREMENTS IN SERUM
CLSI MM22 A : 1ED 2014 MICROARRAYS FOR DIAGNOSIS AND MONITORING OF INFECTIOUS DISEASES
CLSI EP36 : 1EDE 2015 HARMONIZATION OF SYMBOLOGY AND EQUATIONS
CLSI MM3 A3 : 3ED 2015 MOLECULAR DIAGNOSTIC METHODS FOR INFECTIOUS DISEASES
CLSI EP15 A3 : 3ED 2014 USER VERIFICATION OF PRECISION AND ESTIMATION OF BIAS
CLSI EP5 A3 : 3ED 2014 Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline—Third Edition<br>
CLSI C40 A2 : 2ED 2013 MEASUREMENT PROCEDURES FOR THE DETERMINATION OF LEAD CONCENTRATIONS IN BLOOD AND URINE
CLSI EP9 A3 : 3ED 2013 MEASUREMENT PROCEDURE COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES
ISO/TS 17822-1:2014 In vitro diagnostic test systems Qualitative nucleic acid-based in vitro examination procedures for detection and identification of microbial pathogens Part 1: General requirements, terms and definitions

CLSI EP14 A2 : 2ED 2005 EVALUATION OF MATRIX EFFECTS
CLSI EP5 A2 : 2ED 2004 EVALUATION OF PRECISION PERFORMANCE OF QUANTITATIVE MEASUREMENT METHODS
CLSI EP12 A2 : 2ED 2008 USER PROTOCOL FOR EVALUATION OF QUALITATIVE TEST PERFORMANCE
CLSI EP6 A : 1ED 2003 EVALUATION OF THE LINEARITY OF QUANTITATIVE MEASUREMENT PROCEDURES - A STATISTICAL APPROACH
CLSI M29 A3 : 3ED 2005 ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI EP29 A : 1ED 2012 EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE
CLSI EP15 A2 : 2ED 2006 USER VERIFICATION OF PERFORMANCE FOR PRECISION AND TRUENESS
CLSI EP7 A2 : 2ED 2005 INTERFERENCE TESTING IN CLINICAL CHEMISTRY
CLSI MM3 A2 : 2ED 2006 MOLECULAR DIAGNOSTIC METHODS FOR INFECTIOUS DISEASES

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.